Clinical Trial Update: CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL [Phase 1]

View source ↗

Summary

Phase 1 study of CD19/CD22 CAR-T cells in adults with relapsed or refractory acute lymphoblastic leukemia or B-cell lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Lymphoma

Drugs mentioned

• CD19/CD22 CAR-T cells

Snippet

Sponsor: Rong Tao | Conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission | Phase 1 | Status: RECRUITING